Assessment of radio-activation using spectroscopy in medical linear accelerators.
Autorzy:
KwonNH; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Jang YJ; Department of Accelerator Science, Korea University, Sejong, Republic of Korea.; Research Team of Radiological Physics and Engineering, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. Yu S; Research Team of Radiological Physics and Engineering, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.; Department of Radiological Science, Kangwon National University, Samcheock, Republic of Korea. Lee H; Department of Radiological Emergency Preparedness, Korea Institute of Nuclear Safety, Daejeon, Republic of Korea. Choi DH; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Ahn SH; Ewha Medical Research Institute, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. Kim KB; Research Team of Radiological Physics and Engineering, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. Kim JS; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Oncosoft Inc., Seoul, Republic of Korea. Kim DW; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Choi SH; Research Team of Radiological Physics and Engineering, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 18; Vol. 19 (4), pp. e0301435. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
Autorzy:
Go EB; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. Lee JH; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. Cho JH; ProAbTech, Gwangju, 61005, Republic of Korea.; Department of Biotechnology and Bioengineering, Interdisciplinary Program for Bioenergy and Biomaterials, Chonnam National University, Gwangju, 61186, Republic of Korea. KwonNH; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. Choi JI; Department of Biotechnology and Bioengineering, Interdisciplinary Program for Bioenergy and Biomaterials, Chonnam National University, Gwangju, 61186, Republic of Korea. Kwon I; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. .
Uncertainty Evaluation for the Quantification of Urinary Amphetamine and 4-Hydroxyamphetamine Using Liquid Chromatography-Tandem Mass Spectrometry: Comparison of the Guide to the Expression of Uncertainty in Measurement Approach and the Monte Carlo Method with R.
Autorzy:
Kim SY; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Republic of Korea. Shin DW; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Republic of Korea. Hyun J; Department of Applied Statistics, Chung-Ang University, Seoul 06590, Republic of Korea. KwonNH; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Republic of Korea. Cheong JC; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Republic of Korea. Paeng KJ; Department of Chemistry, Yonsei University, Wonju 26493, Republic of Korea. Lee J; Department of Applied Statistics, Chung-Ang University, Seoul 06590, Republic of Korea. Kim JY; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Republic of Korea.
Computation-Aided Design of Albumin Affibody-Inserted Antibody Fragment for the Prolonged Serum Half-Life.
Autorzy:
KwonNH; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea. Lee JH; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea. Kwon I; School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2022 Aug 24; Vol. 14 (9). Date of Electronic Publication: 2022 Aug 24.
S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cells.
Autorzy:
Jo SH; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea. Heo WH; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea. Son HY; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. Quan M; Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea. Hong BS; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. Kim JH; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. Lee HB; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.; Department of Surgery, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Han W; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.; Department of Surgery, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Park Y; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. Lee DS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. KwonNH; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, Korea. Park MC; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, Korea. Chae J; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Biochemistry, Seoul National University College of Medicine, Seoul, Korea. Kim JI; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Biochemistry, Seoul National University College of Medicine, Seoul, Korea. Noh DY; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.; Department of Surgery, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Moon HG; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. .; Department of Surgery, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea. .; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 14; Vol. 11 (1), pp. 1337. Date of Electronic Publication: 2021 Jan 14.
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
Autorzy:
Ku J; Department of Chemical and Biomolecular Engineering and KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. Kim R; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Kim D; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Kim D; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Song S; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Lee K; Department of Chemical and Biomolecular Engineering and KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. Lee N; Department of Chemical and Biomolecular Engineering and KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. Kim M; Department of Chemical and Biomolecular Engineering and KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. Yoon SS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. KwonNH; Medicinal Bioconvergence Research Center, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea. Kim S; Medicinal Bioconvergence Research Center, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea. Kim Y; Department of Chemical and Biomolecular Engineering and KAIST Institute for Health Science and Technology (KIHST), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. . Koh Y; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. .; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. .; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2020 Oct 30; Vol. 3 (1), pp. 630. Date of Electronic Publication: 2020 Oct 30.
An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody.
Autorzy:
Kim DG; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Nguyen TTH; Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea. KwonNH; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Sung J; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Lim S; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Kang EJ; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Lee J; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Seo WY; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea. Kim A; Department of Internal Medicine, Yonsei University College of Medicine, 63 Gil-20, Eonju-ro, Gangnam-gu, Seoul 06229, Korea. Chang YS; Department of Internal Medicine, Yonsei University College of Medicine, 63 Gil-20, Eonju-ro, Gangnam-gu, Seoul 06229, Korea. Shim H; Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea. Kim S; Medicinal Bioconvergence Research Center, College of Pharmacy and College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon 21983, Korea.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2020 May 27; Vol. 10 (6). Date of Electronic Publication: 2020 May 27.
Hybrid Solid-Phase Extraction for Selective Determination of Methamphetamine and Amphetamine in Dyed Hair by Using Gas Chromatography-Mass Spectrometry.
Autorzy:
KwonNH; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Korea. Lee YR; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Korea. Kim HS; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Korea. Cheong JC; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Korea. Kim JY; Forensic Genetics & Chemistry Division, Supreme Prosecutors' Office, Seoul 06590, Korea. .
Characteristics and properties of nano-LiCoO 2 synthesized by pre-organized single source precursors: Li-ion diffusivity, electrochemistry and biological assessment.
Autorzy:
Brog JP; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. Crochet A; Fribourg Center for Nanomaterials FriMat, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. Seydoux J; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. Clift MJD; Adolphe Merkle Institute, University of Fribourg, 1700, Fribourg, Switzerland. Baichette B; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. Maharajan S; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. Barosova H; Adolphe Merkle Institute, University of Fribourg, 1700, Fribourg, Switzerland. Brodard P; College of Engineering and Architecture of Fribourg, University of Applied Sciences of Western Switzerland, Boulevard de Pérolles 80, 1705, Fribourg, Switzerland. Spodaryk M; Laboratory of Materials for Renewable Energy (LMER), ISIC-SB, École Polytechnique Fédérale de Lausanne (EPFL), Valais/Wallis Energypolis, Rue de l'Industrie 17, 1951, Sion, Switzerland. Züttel A; Laboratory of Materials for Renewable Energy (LMER), ISIC-SB, École Polytechnique Fédérale de Lausanne (EPFL), Valais/Wallis Energypolis, Rue de l'Industrie 17, 1951, Sion, Switzerland. Rothen-Rutishauser B; Adolphe Merkle Institute, University of Fribourg, 1700, Fribourg, Switzerland. KwonNH; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. namhee.kwon@unifr.ch. Fromm KM; Department of Chemistry, University of Fribourg, Chemin du Musée 9, 1700, Fribourg, Switzerland. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2017 Aug 22; Vol. 15 (1), pp. 58. Date of Electronic Publication: 2017 Aug 22.
Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction.
Autorzy:
Kim DG; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. [3]. Lee JY; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. [3]. KwonNH; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Fang P; Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, USA. Zhang Q; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida, USA. Wang J; Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, USA. Young NL; Ion Cyclotron Resonance Program, National High Magnetic Field Laboratory, Florida State University, Tallahassee, Florida, USA. Guo M; Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, USA. Cho HY; College of Pharmacy, Korea University, Sejong, Korea. Mushtaq AU; College of Pharmacy, Korea University, Sejong, Korea. Jeon YH; College of Pharmacy, Korea University, Sejong, Korea. Choi JW; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Han JM; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Kang HW; Yuhan Research Institute, Yongin, Korea. Joo JE; Yuhan Research Institute, Yongin, Korea. Hur Y; Yuhan Research Institute, Yongin, Korea. Kang W; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Yang H; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Nam DH; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Lee MS; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Lee JW; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Kim ES; College of Pharmacy, Duksung Women's University, Seoul, Korea. Moon A; College of Pharmacy, Duksung Women's University, Seoul, Korea. Kim K; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Kim D; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Kang EJ; Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. Moon Y; Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. Rhee KH; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Han BW; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Yang JS; Translational Research Center for Protein Function Control, Department of Biotechnology and WCU Department of Biomedical Sciences, Yonsei University, Seoul, Korea. Han G; Translational Research Center for Protein Function Control, Department of Biotechnology and WCU Department of Biomedical Sciences, Yonsei University, Seoul, Korea. Yang WS; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. Lee C; BRI, Korea Institute of Science and Technology, Seoul, Korea. Wang MW; The National Center for Drug Screening, Zhangjiang High-Tech Park, Shanghai, China. Kim S; 1] Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. [2] Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. [3] World Class University Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
Pokaż więcej
Źródło:
Nature chemical biology [Nat Chem Biol] 2014 Jan; Vol. 10 (1), pp. 29-34. Date of Electronic Publication: 2013 Nov 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
